{
    "2020-01-13": [
        [
            {
                "time": "",
                "original_text": "天坛生物：预计2019年净利润同比增长21%左右",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "净利润",
                        "同比增长",
                        "21%",
                        "2019年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：预计全年实现净利润6.14亿元，同比增长21%",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "净利润",
                        "6.14亿元",
                        "同比增长",
                        "21%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：预计2019年净利6.14亿元 同比增21%",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "净利",
                        "6.14亿元",
                        "同比增",
                        "21%",
                        "2019年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：2019年净利逾6亿元 同比预增21％",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "净利",
                        "6亿元",
                        "同比预增",
                        "21%",
                        "2019年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)2019年度净利预增21%至6.14亿元",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "600161.SH",
                        "净利预增",
                        "21%",
                        "6.14亿元",
                        "2019年度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【天风医药 | 专题】2020年血制品批签发报告：整体批签发稳健增长，因子类产品表现优异",
                "features": {
                    "keywords": [
                        "天风医药",
                        "血制品",
                        "批签发",
                        "稳健增长",
                        "因子类产品",
                        "表现优异",
                        "2020年"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "血制品行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}